NeuroOne Medical Tech Analyst Price Targets

Wall Street analyst price targets and consensus rating for NeuroOne Medical Tech (NMTC).

Price Target Range — 5 Quarters

Analyst Consensus — 3 Analysts

3Buy

Consensus RatingBuy# Analysts3Avg. Consensus PT$7Upside to Avg. PT+664.4%

Rating Trend — Last 9 Months

Recent Analyst Actions

すべての評価を見る →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 14, 2026	Maxim Group	Anthony Vendetti	PT Cut	Buy	$13→$5
May 13, 2026	Ladenburg Thalmann	Jeff Cohen	PT Raise	Buy	$2→$9
Mar 2, 2026	Jones Trading	Justin Walsh	Initiate	Buy	$9
Sep 9, 2025	Maxim Group	Anthony Vendetti	Initiate	Buy	$18
May 5, 2025	Ladenburg Thalmann	Jeff Cohen	Initiate	Buy	$9

Analyst Ratings News

PRO
Maxim Group Maintains Buy on NeuroOne Medical Tech, Lowers Price Target to $5

Maxim Group analyst Anthony Vendetti maintains NeuroOne Medical Tech (NASDAQ:NMTC) with a Buy and lowers the price target from $13 to $5.

Benzinga Newsdesk

PRO
Jones Trading Initiates Coverage On NeuroOne Medical Tech with Buy Rating, Announces Price Target of $1.5

Jones Trading analyst Justin Walsh initiates coverage on NeuroOne Medical Tech (NASDAQ:NMTC) with a Buy rating and announces Price Target of $1.5.

Benzinga Newsdesk

PRO
Maxim Group Initiates Coverage On NeuroOne Medical Tech with Buy Rating, Announces Price Target of $3

Maxim Group analyst Anthony Vendetti initiates coverage on NeuroOne Medical Tech (NASDAQ:NMTC) with a Buy rating and announces Price Target of $3.

Benzinga Newsdesk

This Okta Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Avi Kapoor

PRO
Ladenburg Thalmann Initiates Coverage On NeuroOne Medical Tech with Buy Rating, Announces Price Target of $1.45

Ladenburg Thalmann analyst Jeff Cohen initiates coverage on NeuroOne Medical Tech (NASDAQ:NMTC) with a Buy rating and announces Price Target of $1.45.

Benzinga Newsdesk

Stocks Set To Continue Crashing After Worst Selloff Since 2020: Tariff Announcement Was '100% Smoot Hawley Disguised As Thoughtful Policy,' Says Expert

U.S. stock futures continued to decline on Friday after a bloodbath on Thursday following the introduction of Donald Trump's tariffs.

Rishabh Mishra

NeuroOne Medical Technologies Corp

ニュース

パートナーシップ

ベンジンガ・グローバル

NeuroOne Medical Tech Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Maxim Group Maintains Buy on NeuroOne Medical Tech, Lowers Price Target to $5

PRO
Jones Trading Initiates Coverage On NeuroOne Medical Tech with Buy Rating, Announces Price Target of $1.5

PRO
Maxim Group Initiates Coverage On NeuroOne Medical Tech with Buy Rating, Announces Price Target of $3

This Okta Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

PRO
Ladenburg Thalmann Initiates Coverage On NeuroOne Medical Tech with Buy Rating, Announces Price Target of $1.45

Stocks Set To Continue Crashing After Worst Selloff Since 2020: Tariff Announcement Was '100% Smoot Hawley Disguised As Thoughtful Policy,' Says Expert

People Also Watch

People Also Watch

NeuroOne Medical Technologies Corp

ニュース

パートナーシップ

ベンジンガ・グローバル

NeuroOne Medical Tech Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROMaxim Group Maintains Buy on NeuroOne Medical Tech, Lowers Price Target to $5

PROJones Trading Initiates Coverage On NeuroOne Medical Tech with Buy Rating, Announces Price Target of $1.5

PROMaxim Group Initiates Coverage On NeuroOne Medical Tech with Buy Rating, Announces Price Target of $3

This Okta Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

PROLadenburg Thalmann Initiates Coverage On NeuroOne Medical Tech with Buy Rating, Announces Price Target of $1.45

Stocks Set To Continue Crashing After Worst Selloff Since 2020: Tariff Announcement Was '100% Smoot Hawley Disguised As Thoughtful Policy,' Says Expert

People Also Watch

People Also Watch

PRO
Maxim Group Maintains Buy on NeuroOne Medical Tech, Lowers Price Target to $5

PRO
Jones Trading Initiates Coverage On NeuroOne Medical Tech with Buy Rating, Announces Price Target of $1.5

PRO
Maxim Group Initiates Coverage On NeuroOne Medical Tech with Buy Rating, Announces Price Target of $3

PRO
Ladenburg Thalmann Initiates Coverage On NeuroOne Medical Tech with Buy Rating, Announces Price Target of $1.45